For Q3, Elanco Animal Health Expects Revenue Guidance Of $1.03B-$1.06B Compared To The Consensus Of $1.04B, With Adjusted EPS Of $0.08-$0.13 Vs. Consensus Of $0.16
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health has provided its Q3 revenue guidance of $1.03B-$1.06B, which is in line with the consensus of $1.04B. However, its adjusted EPS is expected to be $0.08-$0.13, lower than the consensus of $0.16.
August 07, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Elanco's Q3 revenue guidance is in line with consensus, but its adjusted EPS is expected to be lower than consensus.
Elanco's revenue guidance for Q3 is in line with market expectations, which is a positive sign. However, the company's lower-than-expected EPS guidance could negatively impact investor sentiment and potentially lead to a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100